.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Baxter
Merck
US Department of Justice
McKinsey
Farmers Insurance
Medtronic
McKesson
UBS

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021910

« Back to Dashboard
NDA 021910 describes NORMOCARB HF 35, which is a drug marketed by Dialysis Sups and is included in one NDA. There is one patent protecting this drug. Additional details are available on the NORMOCARB HF 35 profile page.

The generic ingredient in NORMOCARB HF 35 is magnesium chloride; sodium bicarbonate; sodium chloride. There are one hundred and thirty-six drug master file entries for this compound. Additional details are available on the magnesium chloride; sodium bicarbonate; sodium chloride profile page.

Summary for 021910

Tradename:
2
Applicant:
1
Ingredient:
1
Patents:2
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INJECTIONStrength0.21GM/100ML;2.8GM/100ML;9.07GM/100ML
Approval Date:Jul 26, 2006TE:RLD:Yes
Patent:► SubscribePatent Expiration:Oct 31, 2017Product Flag?YSubstance Flag?Delist Request?
Patented Use:USE AS REPLACEMENT SOLUTION, HEMOFILTRATION SOLUTION OR HEMODIAFILTRATION SOLUTION IN CONTINUOUS RENAL REPLACEMENT THERAPY
Patent:► SubscribePatent Expiration:Mar 4, 2023Product Flag?YSubstance Flag?Delist Request?
Patented Use:USE AS REPLACEMENT SOLUTION, HEMOFILTRATION SOLUTION OR HEMODIAFILTRATION SOLUTION IN CONTINUOUS RENAL REPLACEMENT THERAPY

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INJECTIONStrength0.21GM/100ML;3.97GM/100ML;8.3GM/100ML
Approval Date:Jul 26, 2006TE:RLD:Yes
Patent:► SubscribePatent Expiration:Oct 31, 2017Product Flag?YSubstance Flag?Delist Request?
Patented Use:USE AS REPLACEMENT SOLUTION, HEMOFILTRATION SOLUTION OR HEMODIAFILTRATION SOLUTION IN CONTINUOUS RENAL REPLACEMENT THERAPY

Expired Orange Book Patents for NDA: 021910

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dialysis Sups
NORMOCARB HF 25
magnesium chloride; sodium bicarbonate; sodium chloride
SOLUTION;INJECTION021910-001Jul 26, 2006► Subscribe► Subscribe
Dialysis Sups
NORMOCARB HF 35
magnesium chloride; sodium bicarbonate; sodium chloride
SOLUTION;INJECTION021910-002Jul 26, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
UBS
Federal Trade Commission
Chubb
US Department of Justice
Express Scripts
McKesson
US Army
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot